This is the authors' abstract. We don't add key points for this paper.
The global rise in obesity and its associated comorbidities, including type 2 diabetes and cardiovascular disease, presents a major public health challenge. Adipose tissue plays a central role in maintaining energy homeostasis and is a key contributor to the development of obesity and related metabolic disorders [ 1 ]. Among these, brown adipose tissue (BAT) has garnered considerable attention due to its capacity to dissipate energy by promoting triglyceride clearance, glucose uptake, and heat generation through thermogenesis [ 2 , 3 ]. The thermogenic function of BAT is primarily driven by mitochondrial uncoupling protein 1 (UCP1), which uncouples oxidative phosphorylation to produce heat instead of ATP. UCP1-mediated adaptive thermogenesis not only contributes to body temperature regulation but also enhances overall energy expenditure [ 3 , 4 , 5 ]. The discovery of active BAT in adult humans has sparked intense interest in its potential as a therapeutic target for obesity and metabolic disease by promoting energy dissipation and limiting weight gain.
No takes yet. Share an insight, caveat, or question.
Chan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: